Cash Flow Statement

Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Shares Issued Shares Repurchased

Growth Metrics

Ratios

Avai Bio (AVAI) Shares Issued (2018 - 2025)

Avai Bio's Shares Issued history spans 3 years, with the latest figure at $32374.0 for Q1 2024.

On a quarterly basis, Shares Issued rose 416.08% to $32374.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $78664.0, a 1154.01% increase, with the full-year FY2025 number at $20196.0, down 74.33% from a year prior.
Shares Issued hit $32374.0 in Q1 2024 for Avai Bio, up from $10527.0 in the prior quarter.
Over the last five years, Shares Issued for AVAI hit a ceiling of $32374.0 in Q1 2024 and a floor of $6273.0 in Q1 2023.